查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722456

2025-2033年腎臟生物標記市場報告（按生物標記類型、診斷技術、最終用戶和地區）

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球腎臟生物標記市場規模達 14 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 26 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.54%。日益成長的公共衛生問題及其主要風險因素（包括高血壓、糖尿病和心臟病）正在推動市場發展。

腎臟生物標記是尿液分析中存在的細胞、蛋白質、脂質、微小RNA、基因、代謝物或蛋白質體學模式。它們有助於確定腎臟的腎小球濾過率 (GFR)，以分析其正常功能並評估致病過程或對治療介入的藥理反應。由於腎臟生物標記也有助於預測病情進展和計算藥物劑量，因此在全球各地的醫院和診斷實驗室中得到廣泛的應用。

腎臟生物標記市場趨勢：

慢性腎臟病（CKD）是一種發病率和死亡率較高的非傳染性疾病，已逐漸成為全球公共衛生問題，其主要危險因子是糖尿病、高血壓和心臟病。患有 CKD 的人數不斷增加是推動市場成長的關鍵因素之一。此外，腎臟生物標記，包括血中尿素氮（BUN）、血清肌酸酐（SCr）、尿液白蛋白/蛋白和尿量排泄量，用於慢性腎臟病（CKD）的診斷和病情監測。除此之外，全球產業投資者對人類腎臟疾病的新型單一生物標記和製程特異性生物標記組的興趣日益濃厚。這些新型生物標記提供了重要的診斷和預後訊息，並有助於預測對腎絲球病變、急性腎損傷 (AKI) 和常染色體顯性多囊腎 (ADPKD) 的治療反應。除此之外，腎臟生物標記在各種規模的實驗室中變得越來越容易獲得和可行。這與基因組學、表觀遺傳學、轉錄組學、蛋白質組學和代謝組學的發展和整合一起對市場產生了積極影響。預計其他一些因素，如蓬勃發展的醫療保健行業、不斷成長的老年人口以及全球 CKD 臨床試驗數量的增加，也將促進市場的成長。

本報告回答的關鍵問題

  • 2024 年全球腎臟生物標記市場規模？ 2025 年至 2033 年期間全球腎臟生物標記市場的預期成長率為何？
  • COVID-19 對全球腎臟生物標記市場有何影響？
  • 推動全球腎臟生物標記市場發展的關鍵因素有哪些？
  • 根據生物標記類型，全球腎臟生物標記市場如何分佈？
  • 根據診斷技術，全球腎臟生物標記市場如何分佈？
  • 根據最終用戶，全球腎臟生物標記市場是如何分佈的？
  • 全球腎臟生物標記市場的主要區域有哪些？
  • 全球腎臟生物標記市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球腎臟生物標記市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依生物標誌類型

  • 功能性生物標記
    • 關鍵部分
      • 血清肌酸酐
      • 血清胱抑素C
      • 尿液白蛋白
  • 上調蛋白質
    • 關鍵部分
      • 中性粒細胞明膠酶相關脂質運載蛋白 (NGAL)
      • 腎損傷分子-1
      • 白血球介素-18
  • 其他

第7章：市場區隔：透過診斷技術

  • 酵素連結免疫吸附試驗（ELISA）
  • 顆粒增強免疫濁度分析法（PETIA）
  • 比色分析
  • 化學發光免疫分析（CLIA）
  • 液相層析質譜法（LC-MS）

第8章：市場區隔：按最終用戶

  • 醫院
  • 診斷實驗室
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Beckman Coulter Inc. (Danaher Corporation)
    • bioMerieux SA
    • BioPorto A/S
    • Bio-Rad Laboratories Inc.
    • Enzo Biochem Inc.
    • F. Hoffmann-La Roche AG
    • PerkinElmer Inc.
    • Randox Laboratories Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A5273

The global renal biomarkers market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.54% during 2025-2033. The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

Breakup by Biomarker Type:

  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
  • Up-regulated Protein
  • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  • Kidney Injury Molecule-1
  • INTERLEUKIN-18
  • Others

Breakup by Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

  • Hospital
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global renal biomarkers market in 2024?
  • 2.What is the expected growth rate of the global renal biomarkers market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global renal biomarkers market?
  • 4.What are the key factors driving the global renal biomarkers market?
  • 5.What is the breakup of the global renal biomarkers market based on the biomarker type?
  • 6.What is the breakup of the global renal biomarkers market based on the diagnostic technique?
  • 7.What is the breakup of the global renal biomarkers market based on end user?
  • 8.What are the key regions in the global renal biomarkers market?
  • 9.Who are the key players/companies in the global renal biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomarker Type

  • 6.1 Functional Biomarker
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Serum Creatinine
      • 6.1.2.2 Serum Cystatin C
      • 6.1.2.3 Urine Albumin
    • 6.1.3 Market Forecast
  • 6.2 Up-regulated Protein
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • 6.2.2.2 Kidney Injury Molecule-1
      • 6.2.2.3 INTERLEUKIN-18
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

  • 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colorimetric Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Chemiluminescent Immunoassay (CLIA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BioPorto A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Randox Laboratories Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2024
  • Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2024
  • Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
  • Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
  • Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million USD), 2025-2033
  • Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million USD), 2025-2033
  • Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Renal Biomarkers Market: Competitive Structure
  • Table 7: Global: Renal Biomarkers Market: Key Players